Vistusertib,AZD4547,Capivasertib,Sapitinib,Selumetinib,Vandetanib,durvalumab,savolitinib,Olaparib
astrazeneca,sanofi,hutchmed,merck,otsuka
['biomarker', 'durva']
ctdna tumor fraction continue to accumulate data as biomarker. the safir 2 study from and group shown this in durvalumab, with survival outcomes. #liquidbiopsy #asco23 
Assoc Director Clinical Research. Center for Thoracic Oncology.Tisch Cancer Institute. Prof. Icahn School of Medicine at Mount Sinai. Liquid Biopsy. T/RT my own